Related Experiment Video
Updated: Aug 23, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Extended coagulation profile of children with Long Covid: a prospective study
Leonardo Di Gennaro1, Piero Valentini2, Silvia Sorrentino1
1Department of Diagnostic Imaging, Radiotherapy, Oncology and Haematology, Hemorrhagic and Thrombotic Diseases Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Insights
Children with post-COVID condition (PCC) show higher abnormal D-dimer levels, indicating potential endotheliopathy. This study highlights the need for further research into coagulation changes in pediatric PCC.
Area of Science:
- Pediatric Medicine
- Hematology
- Infectious Diseases
Background:
- Emerging data links endotheliopathy to adult post-COVID condition (PCC).
- Research on endothelial changes and coagulation in pediatric PCC is limited.
- SARS-CoV-2 infection can affect various organ systems, including the vasculature.
Purpose of the Study:
- To investigate coagulation profiles and endothelial damage biomarkers in children with PCC.
- To compare coagulation parameters between children with PCC and a control group of recovered children.
- To identify potential links between coagulation abnormalities and persistent symptoms in pediatric PCC.
Main Methods:
- A case-control study involving children under 18 with confirmed SARS-CoV-2 infection.
- Analysis of extended coagulation profiles, including D-dimers and von Willebrand factor (VWF), at 8 and 12 weeks post-infection.
- Comparison of coagulation profiles between children diagnosed with PCC and those who fully recovered.
Main Results:
- Children with PCC showed significantly higher abnormal D-dimer levels compared to recovered children at 8-12 weeks (39.1% vs. 17.2%, p=0.04) and 12 weeks (41% vs. 17.2%, p=0.05).
- A higher proportion of children with three or more persistent symptoms had abnormal D-dimers (64.3% vs. 22.2%, p=0.002).
- While other coagulation markers (VWF, FVIII, RC, Fibrinogen) showed some abnormalities, no significant differences were found between PCC and control groups.
Conclusions:
- Elevated D-dimer levels are more prevalent in children with PCC, particularly those with severe symptoms.
- These findings suggest potential endotheliopathy in pediatric PCC, warranting further investigation.
- Coagulation profiling may aid in understanding and managing long-term effects of SARS-CoV-2 in children.
Abstract:
Emerging data suggests that endotheliopathy changes can be associated with post covid condition (PCC) in adults. Research on the matter in children is lacking. We analyzed an extended coagulation profile including biomarkers of endothelial damage in children with PCC and compared it with a control group of children that fully recovered post- SARS-CoV-2 infection. A case-control study enrolling children below 18 years of age with previous microbiologically confirmed SARS-CoV-2 infection in a pediatric post-covid unit in Italy ≥ 8 weeks after the initial infection. Samples were taken at 8 and 12 weeks after the SARS-CoV-2 diagnosis and analyzed for coagulation profiling (fibrinogen, prothrombin time, international normalized ratio, activated partial thromboplastin time, d-dimers, factor VIII coagulant activity, plasma von Willebrand factor (VWF) antigen and VWF ristocetin cofactor (RC)). We compared coagulation profiles in samples from children identified with PCC (at least one, or three or more symptoms, which could not be explained by an alternative diagnosis, at the 8- and 12-week follow-up assessment using the pediatric Long Covid International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) survey. Seventy-five children were enrolled, 49.3% were females, the median age was 10.2 (IQR 4.9) years. Forty-six (61%) of the children had at least one persisting symptom at the eight weeks post-onset, (PCC8); 39/75 (52%) had persistent symptoms for more than 12 weeks (PCC12) and 15/75(32%) had at least three persisting symptoms (PCC ≥ 3) at 12 weeks. Children with PCC presented more frequently with abnormal D-Dimer levels above the reference range compared to children that had fully recovered at the 8-12 weeks (39.1% vs. 17.2%, p = 0.04), and 12 week follow up or more (41% vs. 17.2%, p = 0.05), and in children with three or more symptoms at 12 weeks follow up compared to those that had recovered (64.3% vs. 22.2%, p = 0.002). For the other coagulation profiles, there were abnormal values detected for VWF, FVIII, RC and Fibrinogen but no significant differences between children with PCC compared to controls. Although the majority of children in our cohort showed coagulation profile within or close to normal ranges, we found that a higher proportion of children with PCC, and specifically those with a more severe spectrum characterized with three or more persisting symptoms, had abnormal D-dimer levels compared to other children that fully recovered from an acute SARS-CoV-2 infection.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Myocarditis II: Clinical Features and Diagnostic Tests

